Concepedia

Dhananjay M. Nawandar

DM

Statistics

Publications

13

Citations

764

H-Index

12

Active since

2012

Affiliations

University of Wisconsin–Madison(Current)

Flagship Pioneering (United States)

Dhananjay M. Nawandar is an author at University of Wisconsin–Madison specializing in molecular virology, oncogenic viruses, and life sciences.

Publications per year

2012–2022

13

Publications

13

Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis

Bhawna Sharma, Dhananjay M. Nawandar, Kalyan C. Nannuru et al. · Molecular Cancer Therapeutics · 2013 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters

Jessica A. Reusch, Dhananjay M. Nawandar, Kenneth L. Wright et al. · Journal of Virology · 2014 · 100 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells

Dhananjay M. Nawandar, Anqi Wang, Kathleen R. Makielski et al. · PLoS Pathogens · 2015 · 100 citations · Full text

Dentistry, Cancer Biology, Oral Biology +17

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

Andrea Bilger, Julie Plowshay, Shidong Ma et al. · Oncotarget · 2017 · 77 citations · Full text

Life Sciences, Immunology, Oncology +10

Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter

Richard J. Kraus, Xianming Yu, Blue-leaf A. Cordes et al. · PLoS Pathogens · 2017 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 13